Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Malcom Rodman Insider Profile
4 Followers
David Malcom Rodman, CMO at Mineralys Therapeutics, Inc., holds 114.24K shares in Mineralys Therapeutics, Inc. (Ticker: MLYS).
David Malcom Rodman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of David Malcom Rodman's holdings
Insider Roles
CMO
Roles that David Malcom Rodman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 11, 2023 - Aug 11, 2024
Return:+13.90%
The most profitable trade made by David Malcom Rodman
David Malcom Rodman's Trading History
List of latest transactions for each holding click on a transaction to see David Malcom Rodman's performance on stock
You May Also Like
David Malcom Rodman insider profile FAQ
What is the percentage of profitable transactions made by David Malcom Rodman?
The percentage of profitable transactions made by David Malcom Rodman is ―.
What is the average return per transaction made by David Malcom Rodman?
The average return per transaction made by David Malcom Rodman is ―.
What stocks does David Malcom Rodman hold?
David Malcom Rodman holds: MLYS stocks.
What was David Malcom Rodman’s latest transaction?
David Malcom Rodman latest transaction was an Uninformative Buy of $9.57K.
What was David Malcom Rodman's most profitable transaction?
David Malcom Rodman’s most profitable transaction was an Informative Sell of MLYS stock on August 11, 2023. The return on the trade was 13.90%.
What is David Malcom Rodman's role in Mineralys Therapeutics, Inc.?
David Malcom Rodman's role in Mineralys Therapeutics, Inc. is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.